14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABEO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Abeona Therapeutics Inc. stock price up 0.631% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 23, 2024 Loss -6.45% PDF

The Abeona Therapeutics Inc. stock price gained 0.631% on the last trading day (Thursday, 25th Apr 2024), rising from $3.17 to $3.19. During the last trading day the stock fluctuated 7.38% from a day low at $3.05 to a day high of $3.28. The price has been going up and down for this period, and there has been a -59.05% loss for the last 2 weeks. Volume fell on the last day by -1 million shares and in total, 1 million shares were bought and sold for approximately $3.50 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $3.20. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABEO Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 0.631%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Abeona Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.74 and $7.30. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Abeona Therapeutics Inc. stock

Abeona Therapeutics Inc. finds support from accumulated volume at $3.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.225 between high and low, or 7.38%. For the last week, the stock has had daily average volatility of 12.00%.

Abeona Therapeutics Inc. is oversold on RSI14 (15). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABEO) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Abeona Therapeutics Inc. to open at $3.17, and during the day (based on 14 day Average True Range), to move between $2.48 and $3.90, which gives a possible trading interval of +/-$0.713 (+/-22.36%) up or down from last closing price. If Abeona Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 44.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.17 (0.63%) than the resistance at $3.41 (6.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Abeona Therapeutics Inc. stock A Buy?

The Abeona Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Abeona Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.563 Sell Candidate Unchanged

Predicted Opening Price for Abeona Therapeutics Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$3.17 ( 0.575%) $3.19

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABEO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.40 6.48 %
R2 3.31 3.78 %
R1 3.26 2.12 %
Current price: 3.19
Support S1 3.09 -3.27 %
S2 3.03 -4.93 %
S3 2.95 -7.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 3.41 6.90 %
Current price 3.19
Support S1 3.17 -0.627%
S2 0 .
S3 0 .

ABEO Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 31, 2000 Mar 31, 2000 Mar 31, 2000 $3,706.25 8.55%

FAQ

What is the symbol for Abeona Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Abeona Therapeutics Inc. is ABEO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Abeona Therapeutics Inc. Stock?
The Abeona Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Abeona Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Abeona Therapeutics Inc. Stock?
Abeona Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Abeona Therapeutics Inc. Stock.

What's the current price of Abeona Therapeutics Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Abeona Therapeutics Inc. (ABEO) share was $3.19.

What is the 52-week high and low for Abeona Therapeutics Inc. Stock?
The 52-week high for Abeona Therapeutics Inc. Stock is $9.01 and the 52-week low is $2.85.

What is the market capitalization of Abeona Therapeutics Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Abeona Therapeutics Inc. is 87.262M.

When is the next earnings date for Abeona Therapeutics Inc.?
The upcoming earnings date for Abeona Therapeutics Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT